Mr. Terry Ruth This is Me

Education

 Web References

1. 1. Contract Manufacturing of Protein Biologics

   www.progenity.com/about.html - [Cached]

   Published on: 6/10/2004   Last Visited: 6/10/2004

   Terry Ruth, Chief Financial Officer Mr. Ruth was Chief Financial Officer from 1991 until early 2002 for Geneva Pharmaceuticals. Geneva, a member of the Novartis Healthcare Group, is one of the largest developers, manufacturers and distributors of generic prescription pharmaceuticals in the United States. At Geneva, Mr. Ruth implemented the strategic plan by funding major facility expansion that doubled manufacturing capacity. Mr. Ruth conducted extensive review and analysis of up to 15 potential mergers, acquisitions, and joint ventures, resulting in the acquisition of two pharmaceutical companies - Invamed and Apothecon, and four joint ventures - Upjohn Pharmaceuticals, Marsam Pharmaceuticals, Smith Kline Beecham, and American Drug Stores. These acquisitions and joint ventures enabled significant market share expansion and increased the company's competitive position in the overall US pharmaceutical market. Mr. Ruth implemented the mergers of Ciba and Geneva Marketing companies in 1996 and the overall Novartis merger, between Ciba Geigy and Sandoz in 1997. This $30 Billion plus merger was the industry's largest in history. Prior to his appointment as chief Financial Officer at Geneva Pharmaceuticals, Mr. Ruth served as Controller from 1985 through 1990. Mr. Ruth received an MBA from Colorado State University and an undergraduate degree in accounting from Florida Atlantic University